tiprankstipranks
Trending News
More News >
Fate Therapeutics (FATE)
NASDAQ:FATE
US Market
Advertisement

Fate Therapeutics (FATE) Technical Analysis

Compare
1,241 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Fate Therapeutics’s (FATE) Moving Averages Convergence Divergence (MACD) indicator is 0.13, suggesting Fate Therapeutics is a Sell.
Fate Therapeutics’s (FATE) 20-Day exponential moving average is 1.35, while Fate Therapeutics’s (FATE) share price is $1.47, making it a Buy.
Fate Therapeutics’s (FATE) 50-Day exponential moving average is 1.22, while Fate Therapeutics’s (FATE) share price is $1.47, making it a Buy.

Fate Therapeutics (FATE) Pivot Points

Oct 21, 2025, 03:28 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.29
1.39
1.46
1.56
1.63
1.73
1.80
Fibonacci
1.39
1.45
1.49
1.56
1.62
1.66
1.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Fate Therapeutics (FATE) Moving Averages

Oct 21, 2025, 03:28 PM
Period
Simple
Exponential
MA5
1.49Sell
1.50Sell
MA10
1.50Sell
1.45Buy
MA20
1.29Buy
1.35Buy
MA50
1.14Buy
1.22Buy
MA100
1.17Buy
1.20Buy
MA200
1.17Buy
1.35Buy
Fate Therapeutics’s (FATE) 10-Day exponential moving average is 1.45, while Fate Therapeutics’s (FATE) share price is $1.47, making it a Buy.
Fate Therapeutics’s (FATE) 100-Day exponential moving average is 1.20, while Fate Therapeutics’s (FATE) share price is $1.47, making it a Buy.
Fate Therapeutics’s (FATE) stock price is $1.47 and Fate Therapeutics’s (FATE) 50-day simple moving average is 1.14, creating a Buy signal.
Fate Therapeutics’s (FATE) stock price is $1.47 and Fate Therapeutics’s (FATE) 100-day simple moving average is 1.17, creating a Buy signal.
Fate Therapeutics’s (FATE) stock price is $1.47 and Fate Therapeutics’s (FATE) 200-day simple moving average is 1.17, creating a Buy signal.

Fate Therapeutics (FATE) Technical Indicators

Oct 21, 2025, 03:28 PM
Name
Value
Implied Action
RSI (14)
60.12
Neutral
STOCH (9,6)
66.60
Neutral
STOCHRSI (14)
77.63
Neutral
MACD (12,26)
0.13
Sell
ADX (14)
40.44
Neutral
Williams %R
-30.65
Buy
CCI (14)
68.54
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
63.26
Neutral
ROC
47.00
Buy
Fate Therapeutics’s (FATE) Relative Strength Index (RSI) is 60.12, creating a Neutral signal.
Fate Therapeutics’s (FATE) Trend Strength Indicator (ADX) is 40.44, creating a Neutral signal.
Fate Therapeutics’s (FATE) Commodity Channel Index (CCI) is 68.54, creating a Neutral signal.
Fate Therapeutics’s (FATE) Price Rate of Change (ROC) is 47.00, creating a Buy signal.

FAQ

Is FATE a Buy, Hold, or Sell?
Based on FATE’s technical indicators, FATE is a Buy.
    What is FATE’s RSI (14)?
    FATE’s RSI (14) is 60.12, which suggests FATE is a Neutral.
      What is FATE’s MACD?
      FATE’s MACD is 0.13, which suggests FATE is a Sell.
        What is FATE’s 5-day moving average?
        FATE’s 5-day moving average is 1.49, which suggests FATE is a Sell.
          What is FATE’s 20-day moving average?
          FATE 20-day moving average is 1.29, which suggests FATE is a Buy.
            What is FATE’s 50-day moving average?
            FATE’s 50-day moving average is 1.14, which suggests FATE is a Buy.
              What is FATE’s 200-day moving average?
              FATE’s 200-day moving average is 1.17, which suggests FATE is a Buy.
                What is FATE’s Williams % R (14)?
                FATE’s Williams % R (14) is -30.65, which suggests FATE is a Buy.
                  What is FATE’s CCI (14)?
                  FATE’s CCI (14) is 68.54, which suggests FATE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis